MicroRNA-221-3p promotes proliferation and invasion in non-small cell lung cancer via targeting Axin2 to regulate Wnt/β-catenin signaling pathway
Authors:
Preprint
- 6 October 2020
- preprint
- Published by Springer Nature in Research Square
Abstract
ObjectiveThe mortality rate of lung cancer ranks first in malignant tumors. Among them, non-small cell lung cancer (NSCLC) accounts for about 85% of all lung cancer patients. In this study, we explore part of the mechanism of development and progression of NSCLC.Methods/ ResultsFirstly, there was an increase in microRNA-221-3p (miR-221-3p) expression and a decrease in Axin2 expression in NSCLC tissues using real-time reverse transcription polymerase chain reaction. Further studies showed that miR-221-3p inhibited the expression of Axin2, which negatively regulated the Wnt signaling pathway. With the method of inhibiting and overexpressing the expression of miR-221-3p and/or Axin2 respectively in NSCLC cell lines A549 and H1975, we found that inhibiting the expression of miR-221-3p leaded to a decrease in cell proliferation, migration and invasion, just like the results of overexpressing Axin2. Relatively speaking, overexpression of miR-221-3P in NSCLC cell lines showed the increase of proliferation as well as the decrease of apoptosis. Thus, we knew that miR-221-3p promoted the migration and invasion of NSCLC cells in vitro. What’s more, according to western blot and EdU assay, we demonstrated that overexpression of miR-221-3p inhibited the expression of Axin2 and subsequently activate classical Wnt/β-catenin signaling pathway. At last, a series of methods were used to identify that miR-221-3p inhibited Axin2 expression, increased cell proliferation, invasion and migration, and decreased cell apoptosis.ConclusionOur results suggest that miR-221-3p inhibits the expression of Axin2 and indirectly activates the typical Wnt/β-catenin signaling pathway, thus promoting tumor proliferation and invasion in NSCLC.Keywords
All Related Versions
This publication has 32 references indexed in Scilit:
- MiR-221-3p targets ARF4 and inhibits the proliferation and migration of epithelial ovarian cancer cellsBiochemical and Biophysical Research Communications, 2018
- microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signalingBiomedicine & Pharmacotherapy, 2018
- Suppression of EIF4G2 by miR‐379 potentiates the cisplatin chemosensitivity in nonsmall cell lung cancer cellsFEBS Letters, 2017
- Circulating miR-221-3p as a novel marker for early prediction of acute myocardial infarctionGene, 2016
- MicroRNA-451 sensitizes lung cancer cells to cisplatin through regulation of Mcl-1Molecular and Cellular Biochemistry, 2016
- MicroRNA-19b/221/222 induces endothelial cell dysfunction via suppression of PGC-1α in the progression of atherosclerosisAtherosclerosis, 2015
- MMP2 and MMP9 participate in S1P-induced invasion of follicular ML-1 thyroid cancer cellsMolecular and Cellular Endocrinology, 2015
- The investigation of miR-221-3p and PAK1 gene expressions in breast cancer cell linesGene, 2015
- MicroRNA in lung cancer diagnostics and treatmentMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2011
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009